8-K
filed May 25, 2023, 7:59 PM ET
ticker CMCO
CIK 0001005229
earnings
confidence high
sentiment positive
materiality 0.75
Columbus McKinnon reports record Q4 sales $253.8M, operating income $27.5M; guides Q1 $235-240M
COLUMBUS MCKINNON CORP
2023-FY EPS reported
$1.68
revenue$936,240,000
- Record Q4 sales $253.8M, +0.2% YoY; adjusted EPS $0.80 vs $0.79.
- Record FY gross margin 36.5%, up 170bps; operating income $97.8M.
- Cash from ops $83.6M for FY; net debt leverage ratio 2.2x.
- Q1 FY24 sales guidance $235-240M, implying high-single digit growth at midpoint.
- montratec acquisition expected to close by May 31, 2023.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
COLUMBUS MCKINNON CORP reported fiscal year 2023 ended March 31, 2023 results: revenue $936.2 million. Guidance reaffirmed.
- Period
- fiscal year 2023 ended March 31, 2023
- Revenue
- $936.2 million
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
Strong execution resulted in record fiscal 2023 sales of $936.2 million and record fourth quarter sales of $253.8 million; FX negatively impacted revenue by $30.6 million for the year
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
COLUMBUS MCKINNON CORP reported fourth quarter fiscal 2023 ended March 31, 2023 results: revenue $253.8 million, net income $13.9 million, EPS $0.48. Guidance reaffirmed.
- Period
- fourth quarter fiscal 2023 ended March 31, 2023
- Revenue
- $253.8 million
- Net income
- $13.9 million
- EPS
- $0.48
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
Strong execution resulted in record fiscal 2023 sales of $936.2 million and record fourth quarter sales of $253.8 million; FX negatively impacted revenue by $30.6 million for the year
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.